Colorectal cancer

• KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors Recruiting
  2024-513285-19-00 1 2025-03-14 "Pancreatic Ductal Adeno Carcinoma"
• A study to learn more about how well treatment with sevabertinib (BAY2927088) tablets works and how safe it is in participants who have a so … Recruiting
  2024-517419-62-00 4 2025-02-28 "HER2 mutation"
• Pan-tumor Study of I-DXd in Subjects with Recurrent or Metastatic Solid Tumors Recruiting
  2023-509632-26-00 9 2025-02-11 "Recurrent or Metastatic Solid Tumors (endometrial cancer (EC"
• Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With Recurrent KRAS/NRAS and BRAF Wild-type Colorectal Cancer Recruiting
  2024-513853-66-00 5 2025-02-04 "KRAS/NRAS and BRAF Wildtype Recurrent, Unresectable or Metas"
• Phase 1 Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancer Recruiting
  2024-516526-66-00 1 2025-01-21 "Metastatic colorectal cancer and Gastric cancer"
• Amivantamab + Chemotherapy Versus Cetuximab + Chemotherapy in Treatment-naïve Participants with KRAS/NRAS and BRAF Wild-type Colorectal Canc … Recruiting
  2024-513852-13-00 5 2025-01-20 "KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left"
• tislelizUMaB in canceR patients with molEcuLar residuaL disease (UMBRELLA) Recruiting
  2023-503316-33-00 5 2024-09-26 "patients with a positive status for molecular residual disea"
• FLUOCOL-1 : Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage Recruiting
  2024-515118-42-00 11 2024-09-10
• Dose Escalation and Dose Expansion Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Patients with Advanced … Recruiting
  2023-508178-27-00 9 2024-07-10 "Participants with Advanced KRASG12C-Mutated Solid Tumors"
• A Phase 1a/1b Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of the CD … Recruiting
  2023-506888-34-00 1 2024-05-22 "Advanced or metastatic solid tumors including hormone recept"
• A Master rollover study to provide continued access to, and assess, long term safety of the study drugs. Recruiting
  2023-506330-73-00 5 2024-03-13 "Advanced (unresectable or metastatic) human epidermal growth"
• An open-label, multicentre, rollover study to evaluate safety and antineoplastic activity of OATD-02 in patients with selected advances and/ … Recruiting
  2024-513006-61-00 3 2023-08-23 "Advanced and/or metastatic solid tumours (colorectal cancer,"
• Platform study of JDQ443 in combinations in patients with advanced solid tumors harboring the KRAS G12C mutation Recruiting
  2023-506716-41-00 9 2023-05-08 "Adult patients with advanced (metastatic or unresectable) KR"
• An open-label, multicentre, dose-escalation, first-in-human phase I study to evaluate safety, tolerability and antineoplastic activity of OA … Recruiting
  2024-510836-31-00 1 2023-02-14 "Advanced and/or metastatic solid tumours (colorectal cancer,"
• A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants with Advanced or … Recruiting
  2023-506517-22-00 9 2022-08-31 "Advanced or Metastatic Colorectal Cancer"
• Neoadjuvant treatment in rectal cancer with radiotherapy followed by atezolizumab and bevacizumab Recruiting
  2024-517119-59-00 4 2019-09-26 "Rectal cancer"
• Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 W … Recruitment ended
  2023-505110-14-00 4 2024-12-02 "Colorectal Cancer"
• Study of JDQ443 in advanced cancer with a specific mutation (G12C) of the KRAS gene Recruitment ended
  2023-508073-87-00 7 2024-11-14 "Advance solid tumors harboring the KRAS G12C mutation"
• A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours Recruitment ended
  2023-506228-10-00 7 2024-06-27 "Pancreatic Ductal Adenocarcinoma"
• A phase I, open-label, multi-center study of KFA115 as a single agent and in combination with pembrolizumab in patients with select advanced … Recruitment ended
  2022-502381-25-01 1 2024-03-15 "Thymic Carcinoma"
• Perioperative/Adjuvant atezolizumab in patients with MSI-high or MMRdeficient stage II high risk or stage III colorectal cancer ineligible f … Recruitment ended
  2024-515224-37-00 4 2023-08-29 "Patients with MSI-high or MMR-deficient stage III colorectal"
• A First-In-Human Trial of the novel T cell Immunotherapy pTTL in Patients with Advanced Colorectal Cancer Recruitment ended
  2024-512296-13-00 1 2023-04-03 "colorectal cancer"
• Phase I, open-label study to evaluate the safety and immune activity of PeptiCRAd-1, an oncolytic virus coated with tumor-specific peptides … Recruitment ended
  2024-517580-23-00 1 2023-03-07 "Sarcoma"
• A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XL092 as Single-Agent and Combination Therapy in Subjects with I … Recruitment ended
  2024-515617-18-00 1 2022-02-14 "Advanced clear cell renal cell carcinoma (ccRCC), non-clear "

Showing 25–48 of 67 trials